Primary Amebic Meningoencephalitis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Primary Amebic Meningoencephalitis

What is the definition of Primary Amebic Meningoencephalitis?
Primary amoebic meningoencephalitis (PAM) is a rare, usually fatal brain infection caused by the single-celled living organism (amoeba), Naegleria fowleri, which is commonly found in warm freshwater environments, such as rivers, lakes, hot springs, swimming pools, contaminated drinking water, water heaters, and soil. Naegleria fowleri is also popularly known as the “brain-eating amoeba.” This amoeba infects humans through the nose, and then travels to the brain wherein it causes primary amoebic meningoencephalitis (inflammation of the brain and the tissues that surround it and the spinal cord ).
What are the symptoms of Primary Amebic Meningoencephalitis?
Symptoms of primary amoebic meningoencephalitis occur within 1 to 9 days after infection and can be similar to bacterial meningitis. Early symptoms may include fever, headache, nausea and vomiting. Later symptoms may include stiff neck, mental confusion, hallucinations, loss of balance, and seizures. Primary amoebic meningoencephalitis is usually fatal within 3 to 7 days.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Primary Amebic Meningoencephalitis?
Treatment for primary amoebic meningoencephalitis is still mostly undefined, as most all individuals infected with Naegleria fowleri have died within days. However, two patients recently infected Naegleria fowleri survived after treatment with the drug, miltefosine, which was administered in combination with other drugs and treatments for the brain swelling associated with primary amoebic meningoencephalitis.
Who are the top Primary Amebic Meningoencephalitis Local Doctors?
Elite in Primary Amebic Meningoencephalitis
Pediatric Infectious Disease
Elite in Primary Amebic Meningoencephalitis
Pediatric Infectious Disease
Referral may be required

University Of Maryland Golisano Children's Hospital

120 Penn Street, 
Baltimore, MD 
Languages Spoken:
English, French
Accepting New Patients
Offers Telehealth

Mark Travassos is a Pediatric Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Travassos is rated as an Elite provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Malaria, Primary Amebic Meningoencephalitis, Bacterial Meningitis, and Giardia Infection. Dr. Travassos is board certified in American Board Of Pediatrics - Pediatrics, 2007 and American Board Of Pediatrics - Pediatric Infectious Diseases, 2011. Dr. Travassos is currently accepting new patients.

Elite in Primary Amebic Meningoencephalitis
Infectious Disease
Elite in Primary Amebic Meningoencephalitis
Infectious Disease
Referral may be required

Montefiore Medical Park At 1575 Blondell

1575 Blondell Avenue, 
Bronx, NY 
Languages Spoken:
English
Accepting New Patients

Johanna Daily is an Infectious Disease provider practicing medicine in Bronx, New York. Dr. Daily is rated as an Elite provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Primary Amebic Meningoencephalitis, Malaria, Togaviridae Disease, Severe Acute Respiratory Syndrome (SARS), and Leg or Foot Amputation. Dr. Daily is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Primary Amebic Meningoencephalitis
Internal Medicine
Elite in Primary Amebic Meningoencephalitis
Internal Medicine

Michigan State University

909 Wilson Rd, 
East Lansing, MI 
Languages Spoken:
English

Terrie Taylor is a primary care provider, practicing in Internal Medicine in East Lansing, Michigan. Dr. Taylor is rated as an Elite provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Primary Amebic Meningoencephalitis, Malaria, Sepsis, and Increased Intracranial Pressure.

What are the latest Primary Amebic Meningoencephalitis Clinical Trials?
DON in Pediatric Cerebral Malaria: A Phase I/IIa Dose-Escalation Safety Study

Summary: The goal of this clinical trial is to evaluate the safety of a single intravenous dose of DON in healthy adults, adults with uncomplicated malaria, and children 12 months-14 years old with clinically defined Cerebral Malaria. The main objectives are: * Evaluate the safety of a single intravenous dose of DON in healthy adults and adults with uncomplicated malaria ( Part 1) * Determine the safety of...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Retrospective Descriptive Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital From 2010 to 2023

Summary: Toxoplasmosis in HIV-positive individuals is well-studied and has a codified management protocol, which is not the case for other immunodeficiencies, except for recent recommendations in the context of hematopoietic stem cell transplantation. A description of this population is necessary to estimate the number of patients affected and to define their specific management (diagnosis, treatment, prev...